How many 8-K filings has Adaptive Biotechnologies Corp filed?

Adaptive Biotechnologies Corp (ADPT) has 9 8-K (Current Event Report) filings on record, spanning Feb 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Adaptive Biotechnologies Corp 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Adaptive Biotechnologies Corp 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Adaptive Biotechnologies Corp (ADPT) — 8-K Filings

All 8-K filings from Adaptive Biotechnologies Corp. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

Adaptive Biotechnologies Files 8-K — Dec 30, 2025 Risk: low
Adaptive Biotechnologies Corporation filed an 8-K on December 30, 2025, reporting other events. The company, incorporated in Washington with its principal execu
Adaptive Biotechnologies Terminates Material Agreement — Aug 18, 2025 Risk: medium
Adaptive Biotechnologies Corporation announced on August 13, 2025, the termination of a material definitive agreement. The company, incorporated in Washington,
Adaptive Biotechnologies Files 8-K on Shareholder Vote — Jun 12, 2025 Risk: low
Adaptive Biotechnologies Corp. filed an 8-K on June 12, 2025, reporting on a matter submitted to a vote of its security holders on June 10, 2025. The filing doe
Adaptive Biotechnologies Files 8-K on Financials — Feb 11, 2025 Risk: low
Adaptive Biotechnologies Corporation filed an 8-K on February 11, 2025, reporting on its results of operations and financial condition. The filing includes fina
Adaptive Biotechnologies Files 8-K — Jun 11, 2024 Risk: low
Adaptive Biotechnologies Corporation filed an 8-K on June 11, 2024, reporting on matters submitted to a vote of security holders and other events that occurred
Adaptive Biotechnologies Appoints New CMO, Officer Departs — Apr 9, 2024 Risk: medium
Adaptive Biotechnologies Corporation announced on April 9, 2024, that its Board of Directors appointed Dr. Jessica S. Markowitz as Chief Medical Officer, effect
Adaptive Biotechnologies Files 8-K on Financials — Apr 5, 2024 Risk: low
Adaptive Biotechnologies Corporation filed an 8-K on April 5, 2024, reporting on its results of operations and financial condition as of April 2, 2024. The fili
Adaptive Biotechnologies Appoints New CMO, Director — Apr 2, 2024 Risk: low
Adaptive Biotechnologies Corp. announced on April 1, 2024, the appointment of Dr. Jessica M. Lang as Chief Medical Officer and the election of Ms. Jennifer D. D
Adaptive Bio Files 8-K on Financial Results — Feb 14, 2024 Risk: low
Adaptive Biotechnologies Corporation filed an 8-K on February 14, 2024, to report its results of operations and financial condition. This routine filing indicat

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX